PAREXEL® Access eHub:

Value Through Evidence

Back to Content Hub

3 important considerations of cardiovascular outcomes trials

Recently, many sponsors have experienced rising demand from regulators and payers to carry out cardiovascular outcomes trials (CVOT), not only for mandated for type 2 diabetes products but increasingly for other diseases and indications. This infographic addresses some of the frequently asked questions surrounding CVOTs presented from a former Cardiovascular Safety Outcome Trials Think Tank Meeting.

Have you considered:

- If you need a CVOT to support your product journey?

- What are the key considerations for performing a CVOT?

- When should a CVOT be carried out?

Infographic: 3 important considerations of cardiovascular outcomes trials

Share this: